RopesTalk

On this Ropes & Gray podcast, health care counsel Leslie Thornton discusses the recent developments and trends related to at-home care coming out of the public health emergency (PHE). She talks about impacts of pandemic-era waivers and flexibilities, focusing on telehealth—including on state licensure, telefraud, HIPAA, and hospital-at-home—remote prescribing, and clinical trials, as well as the future of these flexibilities as we exit the PHE.

On this episode of There Has to Be a Better Way?, co-hosts Zach Coseglia and Hui Chen speak with researchers at Indiana University's Kelley School of Business about the value of corporate compliance programs. Compliance can be (inaccurately) perceived as a “cost center” or an “enabling function,” supporting rather than contributing to product development and business strategy. But business law and ethics professors Todd Haugh and Suneal Bedi tested this idea by assessing the role of compliance in value creation. They discuss findings from their recent study, which explores how consumers value compliance—as a unique product feature—using a statistical technique called conjoint analysis. 

On this episode of Women @ RopesTalk, hosted by health care partner Christine Moundas, life sciences regulatory & compliance counsel Beth Weinman interviews Jennifer Zachary, executive vice president and general counsel of Merck. Jennifer describes her unique trajectory from science major in college to associate chief counsel at the FDA to law firm partner and finally to her role as the top lawyer at Merck. She breaks down the differences and similarities between private and public practice, noting that the desire to protect the public health is just as strong in both places, and shares important advice for early career attorneys: work hard, seek out interesting cases, surround yourself with lawyers you admire, and make sure you’re having fun. Jennifer also describes the invaluable roles that mentorship, sponsorship and diversity efforts played in her transition in-house, and talks about the needle-moving diversity initiative she oversees at Merck.

Join Jeff Thomson, former CEO of the Global Institute of Management Accountants, Shari Littan, Director of Corporate Reporting Research at IMA, and Doug Hileman, an ESG consultant with over 40 years of experience, as they dive into the COSO Internal Control Framework for sustainability reporting. They discuss the urgent need for effective internal control in light of new sustainability requirements. The trio elaborates on the framework's evolution, its importance for transparency, and the collaboration needed across disciplines to enhance sustainability disclosures and corporate governance.

With a choppy fundraising climate and uncertainty about broader global macro trends, as well as in some cases heightened capital constraints, many LPs are keenly focused on ways to improve their investment processes. On this episode of Ropes & Gray’s Alternative Asset Insights podcast series, partners Isabel Dische, Vince Ip and Sean Seelinger focus on some best practices for operational due diligence (ODD) to assess potential risks stemming from a sponsor’s operations.

Join partners Greg Levine and Josh Oyster from Ropes & Gray’s life sciences regulatory and compliance practice group for a special edition of Non-binding Guidance, a podcast series which focuses on current trends in life sciences regulatory law as well as other important developments affecting the life sciences industry. On this episode, Greg and Josh discuss the publication of Ropes & Gray’s U.S. Medical Device Recalls Resource Manual, a reference tool to guide medical device companies considering, planning, or executing product recalls and other field actions.

While the overwhelming majority of Section 337 investigations at the U.S. International Trade Commission involve patent infringement claims, the ITC is empowered to prohibit an extremely broad set of unfair trade practices and unfair methods of competition. In fact, courts have noted that Section 337 is “broad enough to prevent every type and form of unfair practice” associated with the importation of goods into the United States. On this episode of Talkin’ Trade, Ropes & Gray IP litigators Matt Rizzolo, Cassandra Roth, Matt Shapiro, and Brendan McLaughlin discuss the wide variety of claims that may be brought under this subsection of the statute and address some unique aspects of how the ITC adjudicates them. 

On this final episode of Ropes & Gray’s Value-based Care Collides with Competition podcast series, antitrust attorneys Jane Willis and David Young discuss the intersection between federal antitrust enforcement and state regulatory review of health care transactions.

On this episode of There Has to Be a Better Way?, co-hosts Zach Coseglia and Hui Chen talk to Antoine Ferrère, global head of behavioral and data science in the ethics, risk and compliance department at Novartis. With master’s degrees in both management and behavioral science, Antoine discusses how his multidisciplinary team at Novartis applies behavioral and data science at scale to drive ethical behaviors, reduce risks and ensure compliance across all areas of the company. He also discusses the multi-year studies his team has implemented to better understand the role of psychological safety in both speaking up and “listening up.” 

On this episode of Ropes & Gray’s Value-based Care Collides with Competition podcast series, health care partner Christina Bergeron discusses the impact of current and proposed state laws regulating health care access, cost and quality on transactions involving management services organizations (MSOs) and dental support organizations (DSOs).